SCHEMBL7248680

SCHEMBL7248680

O=[N+]([O-])N1CC([N+](=O)[O-])([N+](=O)[O-])CN([N+](=O)[O-])CC([N+](=O)[O-])([N+](=O)[O-])C1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.33
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
NLRP3 Q96P20 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL436830 1.00 GAA (0.33) GAACRHBPCRHR2NLRP3
SCHEMBL11230841 0.90 GAA (0.35) GAACRHBPCRHR2
SCHEMBL11043914 0.85
SCHEMBL7254408 0.85
SCHEMBL13613326 0.74 APEX1 (0.43) GAACRHBPCRHR2
SCHEMBL9921596 0.72 GAA (0.38) GAACRHBPCRHR2NLRP3
SCHEMBL2348600 0.72 GAA (0.30) GAA
SCHEMBL11044912 0.69 GAA (0.31) GAACRHBPCRHR2
SCHEMBL29265156 0.69 CRHBP (0.34) GAACRHBPCRHR2
SCHEMBL17484752 0.67 ALDH1A1 (0.41) GAACRHBPCRHR2NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4452739-A 1,3,3,5,7,7-Hexanitroperhydro-1,5-diazocine, N-nitroso analogs thereof, and processes for their preparation THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1984-06-05 US claimed
CN-117707017-A Coal mine fully-mechanized coal mining equipment control system based on Web data interaction 天津华宁电子有限公司 2024-03-15 CN disclosed
US-6562985-B2 Geminal-dinitro-1-5 diazocine derivatives THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY 2003-05-13 US disclosed
US-20020161248-A1 Geminal-dinitro-1-5 diazocine derivatives CHAPMAN ROBERT DALE (US) 2002-10-31 US disclosed
US-6417355-B1 EXPLOSIVES, PROPELLANT OXIDIZERS; FLUOROAMINATION, NITRATION, SULFONYLATION THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY 2002-07-09 US disclosed
US-4452739-A 1,3,3,5,7,7-Hexanitroperhydro-1,5-diazocine, N-nitroso analogs thereof, and processes for their preparation THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1984-06-05 US disclosed
US-4452739-A 1,3,3,5,7,7-Hexanitroperhydro-1,5-diazocine, N-nitroso analogs thereof, and processes for their preparation THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 1984-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161248-A1 Geminal-dinitro-1-5 diazocine derivatives TNF, TNFRSF1A, AOX1 GAA 874/4885CRHBP 4870/4885CRHR2 4487/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.